Diagnostics & Biomarkers
Monoclonal Antibodies Targeting Ketamine and Its Metabolites
WARF: P240365US01
Inventors: Cody Wenthur, Jillian Kyzer, Natalie Gonzalez Velazquez, Uriel Enriquez
The Invention
UW-Madison researchers have developed monoclonal antibodies to ketamine and monoclonal antibodies to 6-HNK, one of the major metabolites of ketamine. The antibodies are selective enough to bind to the target molecule in the presence of the other. These antibodies could be used as a diagnostic tool in hospitals or by law enforcement. They may be able to be developed into a treatment for ketamine overdose.
Additional Information
For More Information About the Inventors
For current licensing status, please contact Rafael Diaz at [javascript protected email address] or 608-960-9847